Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2NIH 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Classical hematology 4Other hematologic neoplasm 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 27Anemia, Refractory, with Excess of Blasts 27Myelodysplastic Syndromes 22Myeloproliferative Disorders 14Venous Thromboembolism 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Neoplasms 11Lymphoma, Non-Hodgkin 11Leukemia, Myelomonocytic, Chronic 10Anemia 10Primary Myelofibrosis 9Hematologic Neoplasms 9Anemia, Aplastic 9Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Thrombocytopenia 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia 7Fanconi Anemia 7Multiple Myeloma 6Congenital Bone Marrow Failure Syndromes 6Venous Thrombosis 5Pulmonary Embolism 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Follicular 5Febrile Neutropenia 5Anemia, Sickle Cell 5Recurrence 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4

Interventions

decitabine and cedazuridine drug combination 1Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Cytopenia × Classical hematology × 90 days × Clear all
NCT00001620 2026-05-29

Screening for Hematology Branch Protocols

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
10,000 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT05350748 2026-05-08

Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

National Institutes of Health Clinical Center (CC)

Recruiting
1,100 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute

NCT07025512 2026-05-08

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Classical hematology

Cytopenia, Anemia, Thrombocytopenia

NCT06802146 2026-04-23

Early Intervention in High Risk CCUS

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Recruiting
108 enrolled
Classical hematology

Cytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡